title: Thrombotic occlusion of extracardiac conduit 4 months after Fontan surgery.
authors.affiliation: Department of Pediatrics, University of Virginia Health System, Charlottesville, Virginia 22908, USA. seckeler@hotmail.com
authors.forename: Michael D
authors.initials: MD
authors.lastname: Seckeler
authors.forename: Marise D
authors.initials: MD
authors.lastname: D'Souza
authors.forename: James J
authors.initials: JJ
authors.lastname: Gangemi
authors.forename: Andrew W
authors.initials: AW
authors.lastname: Hoyer
authors.forename: K Anitha
authors.initials: KA
authors.lastname: Jayakumar
mesh_terms: D001241:Aspirin / Q000627:therapeutic use; D002675:Child, Preschool; D057915:Drug Substitution; D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D018729:Fontan Procedure / Q000009:adverse effects*; D006083:Graft Occlusion, Vascular / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D006330:Heart Defects, Congenital / Q000503:physiopathology / Q000601:surgery*; D006352:Heart Ventricles / Q000002:abnormalities / Q000503:physiopathology / Q000601:surgery*; D006439:Hemodynamics; D006801:Humans; D008297:Male; D010996:Pleural Effusion / Q000209:etiology; D013927:Thrombosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D013997:Time Factors; D016896:Treatment Outcome; D014654:Vascular Patency; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D005343:Fibrinolytic Agents; D014859:Warfarin; D001241:Aspirin
references.citation: J Am Coll Cardiol. 2011 Aug 2;58(6):645-51
references.pmid: 21798429
references.citation: Circulation. 2008 Jan 1;117(1):85-92
references.pmid: 18071068
references.citation: Cardiol Young. 2011 Apr;21(2):222
references.pmid: 21446074
references.citation: Pediatr Cardiol. 2011 Jan;32(1):32-9
references.pmid: 20967441
references.citation: Ann Thorac Surg. 2002 Jan;73(1):64-8
references.pmid: 11834064